Pharmacy

Tracy Beth Høeg, MD, PhD, was named acting director of the FDA’s Center for Drug Evaluation and Research, effective Dec. 3. Dr. Høeg previously served as senior adviser for clinical sciences in the agency’s Office of the Commissioner and the…

The Anesthesia Patient Safety Foundation and the Institute for Safe Medication Practices issued a joint warning urging hospitals to eliminate vials and ampules of tranexamic acid from perioperative settings due to the risk of fatal wrong-drug, wrong-route errors, according to…

Pharmacists with specialized training can now prescribe buprenorphine to treat opioid use disorder under a federal bill signed into law Dec. 1. The provision is part of the SUPPORT for Patients and Communities Reauthorization Act of 2025, and allows the…

CVS Pharmacy will pay $37.76 million to resolve allegations that it over-dispensed insulin pens and improperly billed federal health programs over a 10-year period. The settlement resolves claims that CVS pharmacies from 2010 to 2020 repeatedly refilled insulin prescriptions too…

For some hospitals and systems, pharmacy is the No. 1 revenue generator, but pharmacy department leaders say they’re often underutilized.  Darren Evans, PharmD, system vice president of pharmacy services and hospital operations at Albany, Ga.-based Phoebe Putney Health System, told…

New York City-based Mount Sinai Health System’s outpatient pharmacy is undergoing a major digital transformation, one that Senior Director of Outpatient Pharmacy Mark Makhinson, PharmD, said is redefining efficiency, patient experience and staff engagement. “We’re really moving toward a digital-first…

In a series of high-impact moves, the FDA is reshaping how it approves and regulates drugs, including accelerating reviews, revising vaccine standards and simplifying biosimilar development. Leadership driving these changes is also in flux: Richard Pazdur, MD, who was named director…

In a first, the World Health Organization has issued a guideline on GLP-1s, a drug class that up to 1 in 8 U.S. adults report using, according to KFF research.  The WHO’s guideline, published Dec. 1 in JAMA, recommends long-term…

Eli Lilly has lowered the price of its GLP-1 drug Zepbound (tirzepatide) in single-dose vials, with the starting dose now available for $299 per month through the company’s direct-to-consumer platform, LillyDirect. The drugmaker said in a Dec. 1 news release…

The U.S. and the United Kingdom reached an agreement in principle to address pharmaceutical pricing disparities and secure investment under the U.S.-U.K. Economic Prosperity Deal. According to a Dec. 1 news release from the U.S. trade representative’s office, the U.K.…